Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)
China · Delayed Price · Currency is CNY 11.55
+0.06 (0.52%)
Jun 9, 2026, 3:04 PM CST
SHE:300601 Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, SHE:300601 stock has a consensus rating of "Buy" and an average price target of ¥16.44. The average 1-year stock price forecast is 42.34% higher than the current stock price, while the lowest is ¥15.00 (+29.87%) and the highest is ¥18.82 (+62.94%).
Price Target: ¥16.44 (+42.34%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SHE:300601 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 5 | 5 | 5 | 5 |
Financial Forecast
Revenue This Year
2.80B
from 2.67B
Increased by 4.74%
Revenue Next Year
3.10B
from 2.80B
Increased by 10.84%
EPS This Year
0.26
from 0.07
Increased by 271.43%
EPS Next Year
0.36
from 0.26
Increased by 38.46%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.9B | ||
| Avg | 2.8B | ||
| Low | 2.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 10.1% | ||
| Avg | 4.7% | ||
| Low | -2.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 0.26 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 271.4% | ||
| Low | - |